Population
Sprague-Dawley rats (n=47 total: 23 control, 24 Ang II-infused)
Comparison
Angiotensin II 60 ng/min subcutaneously for 13… vs Control rats without Angiotensin II infusion
Design
Preclinical
Follow-up
13 days
Authors
Loading...
Suggests Ang II impairs nNOS buffering of afferent tone in rats; leaves open relevance to human hypertension.
Chronic Angiotensin II infusion impairs the ability of nNOS-derived nitric oxide to buffer afferent arteriolar constriction in response to increased distal tubular flow.
Ichihara et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: